Berlin.
The first vaccine against the RS virus is approved. Charité researcher Beate Kampmann says who should be vaccinated in the future.
In the fight against the RS virus, the renowned infection researcher Beate Kampmann advises a broad vaccination campaign as soon as a vaccine against the virus is approved in Germany: “It makes sense to protect small children, risk groups and older people against RSV to vaccinate, because this is where the more serious complications occur,” said the director of the Institute for International Health at the Charité in Berlin. A vaccine against the respiratory syncytial virus (RSV) was approved for the first time in the United States at the end of the week.
Also read: Sharp increase in clinical cases with RS virus
RS virus: Vaccine for pregnant women could come in the fall
Kampmann also expressed his confidence that there would soon be an RSV vaccine that pregnant women could be vaccinated with in order to protect newborns in this way: “I myself have been involved in studies that deal with this, especially protection for infants by vaccinating the mothers during pregnancy.” The Vaccine with this indication, advice is currently being given to the approval authorities. “We expect a decision in the fall,” said Kampmann. Kampmann is an expert in pediatric infectiology and international child health.
Background:This is how dangerous the RS virus is for small children
More articles from this category can be found here: Politics
